The Ultimate GLP-1 Guide (2026): Everything You Need to Know About Semaglutide, Tirzepatide, and Retatrutide
The most comprehensive GLP-1 resource online. Covers every medication, mechanism of action, clinical data, side effects, costs, comparisons, and practical guidance for weight loss treatment in 2026.
More on Ultimate Guide
The Definitive Resource
This is the most comprehensive GLP-1 guide available online, covering every aspect of GLP-1 weight loss medications. Bookmark this page as your single reference for everything GLP-1 related. Last updated April 2026 with the latest clinical data and pricing.
Table of Contents
1. What Are GLP-1 Medications?
GLP-1 receptor agonists are a class of medications that mimic the naturally occurring hormone GLP-1 (glucagon-like peptide-1), which is produced in the gut after eating. These medications were originally developed for type 2 diabetes and were later found to produce significant weight loss. They represent the most effective non-surgical weight loss treatment ever developed, producing 15-25% body weight reduction in clinical trials.
The three GLP-1 medications available through Trimi are semaglutide ($99/mo), tirzepatide ($125/mo), and retatrutide. Each works through slightly different receptor combinations, producing varying levels of weight loss and metabolic benefits. All are administered as once-weekly subcutaneous injections.
2. How GLP-1 Medications Work
Brain: Appetite Reduction
GLP-1 receptors in the hypothalamus control hunger and satiety signals. GLP-1 medications amplify satiety signaling, reducing appetite by 30-50%. Patients describe this as turning down the volume on "food noise" -- the constant background thinking about food that drives overeating. This is the most important mechanism for weight loss.
Stomach: Delayed Gastric Emptying
GLP-1 slows the rate at which food leaves the stomach, extending the feeling of fullness after meals. This means smaller meals feel satisfying for longer. While this contributes to weight loss, it also explains the GI side effects (nausea) that some patients experience during dose titration.
Pancreas: Improved Insulin Sensitivity
GLP-1 enhances glucose-dependent insulin secretion and suppresses inappropriate glucagon release. This improves blood sugar control and reduces insulin resistance. Tirzepatide adds GIP receptor activation for enhanced insulin sensitization. These effects explain why GLP-1 medications are so effective for type 2 diabetes.
Heart and Vessels: Cardiovascular Protection
The SELECT trial demonstrated that semaglutide reduces major adverse cardiovascular events (heart attack, stroke, cardiovascular death) by 20% in overweight/obese patients. This cardioprotective effect occurs independent of weight loss and represents a paradigm shift in obesity medicine -- treating excess weight now directly reduces heart disease risk.
3. The Three GLP-1 Medications Compared
| Feature | Semaglutide | Tirzepatide | Retatrutide |
|---|---|---|---|
| Brand Name | Wegovy/Ozempic | Zepbound/Mounjaro | Investigational (Lilly) |
| Mechanism | GLP-1 receptor agonist | Dual GLP-1 + GIP agonist | Triple GLP-1 + GIP + Glucagon agonist |
| Weight Loss | 15-17% | 20-22% | 24%+ |
| Trimi Price | $99/mo | $125/mo | Ask us |
| Approval Status | FDA 2021 | FDA 2023 | Phase 3 (2027-28 est.) |
| Key Trials | STEP 1-5 | SURMOUNT 1-4 | TRIUMPH 1-5 |
4. Side Effects and Safety
GLP-1 medications share a common side effect profile dominated by gastrointestinal symptoms. These are typically mild, transient, and manageable with proper dose titration and supportive care. The most important safety data shows that serious adverse events are rare and the medications provide cardiovascular protection.
Common Side Effects
- Nausea (25-44%) -- usually resolves in 2-4 weeks
- Diarrhea (21-30%) -- mild, self-limiting
- Constipation (14-24%) -- manageable with fiber/water
- Only 4-7% discontinue due to side effects
Rare but Serious
- Pancreatitis (very rare, <0.3%)
- Gallbladder disease (1-2%, related to rapid weight loss)
- Thyroid C-cell tumors (rodent data, no human cases confirmed)
- Contraindicated with MTC/MEN2 family history
5. Cost and Affordability
Semaglutide
$99/mo
Brand: $1,349/mo
Save $15,000/year
Tirzepatide
$125/mo
Brand: $1,060/mo
Save $11,220/year
Retatrutide
Ask us
Compounded available
Contact for pricing
Trimi pricing includes medication, provider consultation, and free shipping. No insurance needed. No contracts. Cancel anytime.
6. Who Is Eligible?
7. Getting Started with Trimi
Complete Assessment
Online medical questionnaire reviewed by board-certified provider
Provider Review
Your provider selects the right medication and starting dose
Medication Ships
Compounded medication shipped free to your door
Ongoing Support
Regular check-ins, dose adjustments, and medical oversight
Medical Disclaimer: This guide is for educational purposes only and does not constitute medical advice. Individual results vary. GLP-1 medications require a prescription and medical supervision. Consult a healthcare provider before starting any weight loss medication.
Frequently Asked Questions
What is a GLP-1 medication and how does it work?
GLP-1 (glucagon-like peptide-1) medications mimic a natural gut hormone that regulates appetite and blood sugar. They work in the brain to reduce hunger, slow stomach emptying to increase fullness, and improve insulin sensitivity. The result is significant, sustained weight loss of 15-25% of body weight.
Which GLP-1 medication is best for weight loss?
In clinical trials: retatrutide shows the highest weight loss (24%+ at 48 weeks), tirzepatide is second (20-22%, SURMOUNT trials), and semaglutide is third (15-17%, STEP trials). However, 'best' depends on individual factors including cost, insurance, health conditions, and personal response. At Trimi: semaglutide is $99/mo, tirzepatide is $125/mo.
Are GLP-1 medications safe?
GLP-1 medications have extensive safety data from clinical trials involving 30,000+ patients. Common side effects (nausea, diarrhea, constipation) are usually mild and transient. Serious adverse events are rare (<1%). Semaglutide has been prescribed to millions globally since 2017. The cardiovascular benefits (20% reduction in major adverse cardiac events) are an important safety advantage.
How much do GLP-1 medications cost?
Brand-name: Wegovy $1,349/mo, Zepbound $1,060/mo without insurance. Compounded through Trimi: semaglutide $99/mo (93% savings), tirzepatide $125/mo (88% savings). Compounded medications use the same active ingredient prepared by licensed pharmacies. No insurance needed.
Do I have to take GLP-1 medications forever?
Current evidence shows that most patients regain weight after stopping GLP-1 medications. Maintenance dosing (often at a lower dose) is recommended for long-term weight management. Some patients can taper to lower doses while maintaining results with lifestyle changes. The analogy is similar to blood pressure medication -- it manages a chronic condition.
What makes Trimi different from other GLP-1 providers?
Trimi offers all three major GLP-1 medications (semaglutide, tirzepatide, retatrutide) at the most competitive prices ($125/mo and $125/mo). Board-certified providers, compounded by licensed pharmacies, free shipping, no contracts, and comprehensive medical oversight. Trimi is the only provider offering all three medications.
Start Your GLP-1 Weight Loss Journey Today
Compounded semaglutide from $99/mo or tirzepatide from $125/mo. All three medications. One provider.
View Treatment OptionsSources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).